Showing results (441-450 of 2,398) with videos related to
Sort By:
Pageof 240
Hemoglobin|January 1, 1987
Post-synthetic modification in vivo of the major hemoglobin beta chain in the ratL M Garrick, M L Chu, P Rusnak-Smalley, et al.Hemoglobin|May 23, 2022
A New Case of Hb Headington (HBB: c.217A>C) Due to a New DNA Transversion, Found in a Patient with Type 2 Diabetes MellitusYu Liu, Bo Liu, Ying-Chun Qiao, et al.Hemoglobin|May 13, 2022
Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community HospitalAndrew BindingHemoglobin|January 1, 1986
Hb Himeji or beta 140 (H18) Ala----Asp. A slightly unstable hemoglobin with increased beta N-terminal glycationY Ohba, T Miyaji, M Murakami, et al.Hemoglobin|January 1, 1986
Hemoglobin Woodville: alpha (2)6(A4) aspartic acid----tyrosineP F Como, S Barber, R E Sage, et al.Hemoglobin|November 22, 2022
Targeted Next-Generation Sequencing Reveals a Large Novel β-Thalassemia Deletion that Removes the Entire HBB GeneZhen-Zhen Yin, Jian Yao, Feng-Xiang Wei, et al.Hemoglobin|October 10, 2009
Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. experience from a Cyprus model and its use as a paradigm for future applicationsAnita Kolnagou, George J KontoghiorghesHemoglobin|October 10, 2009
Thalassemia incidence and treatment in China with special reference to Shenzhen City and Guangdong provinceChang-Gang Li, Chun-Fu Li, Qi Li, et al.Hemoglobin|October 10, 2009
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocolAnita Kolnagou, Dilek Yazman, Charalambos Economides, et al.Hemoglobin|October 14, 2009
The role of labile iron in kidney disease and treatment with chelationSudhir V Shah, Mohan M RajapurkarPageof 240